Loading…

Senzime announced that a leading UK NHS hospital trust has ordered 70 TetraGraph systems to standardize neuromuscular monitoring. The contract was secured by Senzime's UK partner Healthcare 21, and annual usage is expected to exceed 15,000 TetraSens sensors.
“This is a strategic win for us in the UK market and a clear signal that the NHS is accelerating the transition to the latest advancements in neuromuscular monitoring.”inderes.fi
Summarized from public sources; check the original articles before acting on it.